A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer Inc/BioNTech SE vaccine by two-thirds, and it is not clear if the shot will...
https://ift.tt/eA8V8J
https://ift.tt/eA8V8J
Comments
Post a Comment